Transplant Research and Risk Management is an esteemed Open Access journal dedicated to advancing the fields of transplantation and risk analysis in healthcare. Published by DOVE MEDICAL PRESS LTD based in New Zealand, the journal has been facilitating open dissemination of research since its inception in 2010, ensuring that critical findings reach a global audience. With a focus on statistical methodologies applicable to transplant science, the journal is recognized in the Q4 category in both Transplantation and Statistics, Probability and Uncertainty fields as of 2023. Despite its current challenges in ranking, it provides an essential platform for studies that explore innovative approaches to enhance transplant outcomes and evaluate associated risks. Researchers, professionals, and students keen on the latest advancements and methodologies in this dynamic area of medicine will find valuable resources and interdisciplinary insights that propel their inquiries and practice. The journal accepts submissions that contribute to its goal of improving transplant methodologies, patient management, and broader public health strategies.

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.

Experimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.

Current Opinion in Organ Transplantation, published by Lippincott Williams & Wilkins, serves as a leading journal in the fields of immunology and transplantation, providing insightful reviews and expert opinions that shape the discourse in these vital areas of medical research. With an impact factor showcasing its significance and influence in the academic community, this journal is ranked in the Q2 category for both Immunology and Transplantation according to the 2023 metrics, affirming its essential role in advancing knowledge and understanding. Spanning from its inception in 2001 through to 2024, Current Opinion in Organ Transplantation offers a platform for researchers, professionals, and students to engage with the latest advancements and trends, contributing to the ongoing dialogue that drives innovation in organ transplantation and immunological therapies. Although the journal does not currently offer open access options, its rigorous peer-review process and reputable publisher ensure the highest quality of research dissemination, making it an invaluable resource for those invested in the future of organ transplantation.

The International Journal of Organ Transplantation Medicine, published by the Avicenna Organ Transplant Center, stands as a vital resource for the field of transplantation medicine. Established to advance scientific knowledge and clinical practices, this open access journal has been supporting the global research community since 2010, ensuring that groundbreaking findings are easily accessible to researchers, professionals, and students alike. With its ISSN of 2008-6490 and E-ISSN 2008-6482, the journal consistently showcases high-quality, peer-reviewed articles, addressing critical advancements in transplantation techniques, patient care, and immunology. Renowned for its commitment to excellence, it holds a Q3 ranking in transplantation for 2023 and ranks #32 out of 54 in the Scopus medicine transplantation category, placing it in the 41st percentile. Researchers are encouraged to submit their work, contributing to the journal's goal of improving outcomes in organ transplantation and fostering collaboration across disciplines.

American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.

Transplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.